Dechra Pharmaceuticals plc 3.8% Potential Upside Indicated by RBC Capital Markets

Broker Ratings

Dechra Pharmaceuticals plc with EPIC/TICKER (LON:DPH) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘SECTOR PERFORMER’ this morning by analysts at RBC Capital Markets. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. RBC Capital Markets have set a target price of 2560 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 3.8% from the opening price of 2466 GBX. Over the last 30 and 90 trading days the company share price has decreased 364 points and decreased 498 points respectively. The 52 week high share price is 3090 GBX while the year low stock price is currently 2030 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,814.59 GBX and a 200 day moving average of 2,831.60. There are currently 102,867,477 shares in issue with the average daily volume traded being 415,962. Market capitalisation for LON:DPH is £2,457,298,340 GBP.

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp

AIM All Share Index